Actinium to present preclinical data on ATNM-400 at EANM congress

🌐 Investing.com (Cyprus) —
Actinium to present preclinical data on ATNM-400 at EANM congress

AI Summary

Actinium Pharmaceuticals plans to present preclinical data on its ATNM-400 candidate at the EANM congress. The announcement concerns early-stage medical research, with no results provided in the item.

Health preclinical research ATNM-400 medical conference EANM Actinium Pharmaceuticals

Read original source →